摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one | 60868-25-9

中文名称
——
中文别名
——
英文名称
1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one
英文别名
1,2-Dimethyl-2,3-dihydro-chinazolon-(4);2,3-Dihydro-1,2-dimethyl-chinazol-4-on;2,3-Dihydro-1,2-dimethyl-chinazolon-(4);1,2-dimethyl-2,3-dihydro-1H-quinazolin-4-one;1,2-Dimethyl-4(3h)-quinazolinone;1,2-dimethyl-2,3-dihydroquinazolin-4-one
1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one化学式
CAS
60868-25-9
化学式
C10H12N2O
mdl
——
分子量
176.218
InChiKey
ILAGIUMQYBZMSE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one乙酸酐吡啶 作用下, 反应 3.0h, 以97%的产率得到3-acetyl-1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one
    参考文献:
    名称:
    Yamato, Masatoshi; Horiuchi, Jiroh; Takeuchi, Yasuo, Chemical and pharmaceutical bulletin, 1981, vol. 29, # 10, p. 3055 - 3059
    摘要:
    DOI:
  • 作为产物:
    描述:
    Glomerin 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以60%的产率得到1,2-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one
    参考文献:
    名称:
    Yamato, Masatoshi; Horiuchi, Jiroh; Takeuchi, Yasuo, Chemical and pharmaceutical bulletin, 1981, vol. 29, # 10, p. 3055 - 3059
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • YAMATO, MASATOSHI;HORIUCHI, JIROH;TAKEUCHI, YASUO, CHEM. AND PHARM. BULL., 1981, 29, N 10, 3055-3059
    作者:YAMATO, MASATOSHI、HORIUCHI, JIROH、TAKEUCHI, YASUO
    DOI:——
    日期:——
  • HORIUCHI, JIROH;TAKEUCHI, YASUO;YAMATO, MASATOSHI, CHEM. AND PHARM. BULL., 1981, 29, N 11, 3130-3133
    作者:HORIUCHI, JIROH、TAKEUCHI, YASUO、YAMATO, MASATOSHI
    DOI:——
    日期:——
  • NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION
    申请人:Otsuka Pharmaceutical Co., Ltd.
    公开号:EP2467364A2
    公开(公告)日:2012-06-27
  • [EN] NITROGEN-CONTAINING COMPOUND AND PHARMACEUTICAL COMPOSITION<br/>[FR] COMPOSÉ CONTENANT DE L'AZOTE ET COMPOSITION PHARMACEUTIQUE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2011021726A2
    公开(公告)日:2011-02-24
    The present invention provides a novel diazepine compound that blocks the IKur current or the Kv1.5 channel potently and more selectively than other K+ channels. The present invention relates to a diazepine compound represented by General Formula (1) or a salt thereof, wherein R1, R2, R3, and R4 are each independently hydrogen, lower alkyl, cyclo lower alkyl or lower alkoxy lower alkyl; R2 and R3 may be linked to form lower alkylene; A1 is lower alkylene optionally substituted with one or more substituents selected from the group consisting of hydroxyl and oxo; Y1 and Y2 are each independently -N= or -CH=; and R5 is group represented by (2) wherein R6 and R7 are each independently hydrogen or organic group; R6 and R7 may be linked to form a ring together with the neighboring group -XA-N-XB-; XA and XB are each independently a bond, lower alkylene, etc.
  • Yamato, Masatoshi; Horiuchi, Jiroh; Takeuchi, Yasuo, Chemical and pharmaceutical bulletin, 1981, vol. 29, # 10, p. 3055 - 3059
    作者:Yamato, Masatoshi、Horiuchi, Jiroh、Takeuchi, Yasuo
    DOI:——
    日期:——
查看更多